The page is the record's research on the issuer — no analyst, no rating, no view. # Inhibrx Biosciences, Inc. (NASDAQ: INBX) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing The issuer is Inhibrx Biosciences, Inc., listed on NASDAQ under the ticker INBX, with ISIN US45720N1037. The LEI is not on the record, as no GLEIF record carries the exact legal name in jurisdiction US-DE. The security type is Corporate, the segment is not on the record, the sector is 2836 Biological Products, (No Diagnostic Substances), and the jurisdiction is United States, Delaware. The issuer is listed and not halted. ## The disclosure read The record holds 53 filings in the twelve months to 2026-11-08, across 32 filing days. The median gap between filing days is 6 days. The median days from latest filing to record date is 11 days on this record, and the latest filing is dated 2026-10-28 and is of type regulatory_filing. The NASDAQ exchange median is 6.0 days for cadence gap, 52 filings and 5.0 days latency across 4359 issuers. The sector median for 2836 Biological Products, (No Diagnostic Substances) is 5.5 days for cadence gap, 65.5 filings and 4.0 days latency across 176 issuers. By type, the window holds 3 agm_egm, 8 corporate_news, 18 directors_dealings, 16 regulatory_filing and 8 results filings. ## Auditor The auditor of record is BDO USA, P.C., located in San Diego, California. The record holds no auditor changes. ## Events and halts The record holds no delisting, listing or name change lines. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as exchange tier transfers are not EDGAR filings. The halt flag reads listed, not halted. ## Orderability The outcome is not determinable, because the chapter's orderability section carries no client categories and so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04. ## Coverage No research house was found on the pages read, and the count is 0. ## Open research No openly published research notes were found, and the count is 0. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The issuer years sealed are 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12. ## Sources 8 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin) - https://data.sec.gov/submissions/CIK0002007919.json (identity.jurisdiction) - https://mcp.us-cm-kg.ai/events/NASDAQ/INBX (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://www.sec.gov/Archives/edgar/data/2007919/000200791926000006/inbx-20251231.htm (the auditor) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.us-cm-kg.ai/record/NASDAQ/INBX (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/INBX · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp